Using the publicly available CSIOVDB database, FSHR and LHCGR expression was increased in early-stage ovarian cancer (stage I) compared to stage II, III or IV cancers (p < 0.01, Figure 1a,c). This evidence concerns the gene FSHR and ovarian carcinoma.